ПОРАЖЕНИЕ СЕРДЦА КАК ОДИН ИЗ СИНДРОМОВ COVID-19 ИНФЕКЦИИ
Рубрики: ОБЗОРЫ
Аннотация и ключевые слова
Аннотация (русский):
В настоящее время наиболее острой и серьезной проблемой во всем мире является пандемия, вызванная коронавирусной инфекцией. Известно, что вирус повреждает альвеоциты легких, вызывая пневмонию и/или острый респираторный дистресс синдром. Однако, не только легкие являются мишенью поражения SARS-CoV-2. В статье представлен обзор случаев поражения сердца при COVID-19 инфекции. Нами были изучены зарубежные и отечественные научные публикации, касающиеся случаев поражения сердечно-сосудистой системы в целом, и сердца в частности. Изучение, анализ и обзор данных проводился в период с декабря 2019 года по июнь 2020 года. Научные работы по данной теме были найдены на таких платформах, как PubMed, Europe PubMed Central, Elsevier Science Direct, Elsevier Open Science, Springer Open, Bielefeld Academic Search Engine и Научная электронная библиотека eLibrary.ru.

Ключевые слова:
COVID-19, поражение сердца, тропонин, миоглобин, NT-proBNP, COVID-19 инфекция, SARS-CoV-2
Текст
Текст произведения (PDF): Читать Скачать
Список литературы

1. Информационные ресурсы Министерства здравоохранения РФ для мониторинга эпидемиологической обстановки по COVID-19. Доступно по: https://covid19.rosminzdrav.ru/ Ссылка активна на 05.10.2020.

2. Временные методические рекомендации диагностика, профилактика коронавирусной новой лечение и 19-covid инфекции [архив] Доступно по: https://static0.rosminzdrav.ru/system/ attachments/attaches/000/050/584/original/03062020_ МR_COVID-19_v7.pdf

3. Наименование заболевания, вызванного коронавирусом (COVID-19), и вирусного возбу- дителя. Всемирная организация здравоохранения. Дата обращения 27 июня 2020 [архив]. Доступно по: https://www.who.int/ru/emergencies/diseases/ novel-coronavirus-2019/technical-guidance/naming- the-coronavirus-disease-(covid-2019)-and-the-virus- that-causes-i

4. Huang, C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., Cheng Z., Yu T., Xia J., Wei Y., Wu W., Xie X., Yin W., Li H., Liu M., Xiao Y., Gao H., Guo L., Xie J., Wang G., Jiang R., Gao Z., Jin Q., Wang J., Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5.

5. Fang L., Wenhui L., Michael F., Stephen C.H. Structure of SARS coronavirus spike receptor-binding domain сomplexed with receptor. The Journal of Clinical Endocrinology and Metabolism.950;10(10):1361–2. https://doi.org/10.1126/SCIENCE.1116480.

6. Kuba K., Imai Y., Rao S., Gao H., Guo F., Guan B., Huan Y., Yang P., Zhang Y., Deng W., Bao L., Zhang B., Liu G., Wang Z., Chappell M., Liu Y., Zheng D., Leibbrandt A., Wada T., Slutsky A. S., Liu D., Qin C., Jiang C., Penninger J. M. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus induced lung injury. Nature Medicine. 2005;11(8):875– 9. doi: 10.1038/nm1267.

7. Vaarala M. H., Porvari K. S., Kellokumpu S., Kyllцnen A. P., Vihko P. T. Expression of transmembrane serine protease TMPRSS2 in mouse and human tissues. Journal of Pathology. 2001;193(1):134–40. https://doi.org/10.1002/1096-9896(2000)9999:9999<::AID- PATH743>3.0.CO;2-T.

8. Liu Y., Yan L., Wan L., Xiang T., Le A., Liu J.,Peiris J. S., Poon L. M., Zhang W. Viral dynamics in mild and severe cases of COVID-19. The Lancet Infectious Diseases. 2019; 2020(20):2019–20. https://doi.org/10.1016/S1473-3099(20)30232-2

9. Kwong J. C. , Schwartz K. L., Campitelli M.A., Chung H., Crowcroft N. S. , Karnauchow T., Katz K., Ko D. T., McGeer A. J., McNally D., Richardson D. C., Rosella L. C., Simor A., Smieja M., Zahariadis G., Gubbay J. B. Acute myocardial infarction after laboratory-confirmed influenza infection. The New England Journal of Medicine. 2018;378(26):2538–41. https://doi.org/10.1056/NEJMoa1702090.

10. Smeeth L., Thomas S. L., Hall A. J., Hubbard R., Farrington P. Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. The New England Journal of Medicine.2004;351(25):2611–8. https://doi.org/10.1056/NEJMoa041747.

11. Driggin E., Madhavan M. V., Bikdeli B., Chuich T., Laracy J., Biondi-Zoccai G., Brown T.S., Nigoghossian C. D., Zidar D. A., Haythe J., Brodie D., Beckman J. A, Kirtane A. J., Stone G. W., Krumholz H. M., Parikh S. A. Cardiovascular considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID-19) pandemic. Journal of the American College of Cardiology. 2020;75(18):2352-2371. https://doi.org/10.1016/j. jacc.2020.03.031.

12. Tang N., Li D., Wang X., Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. Journal of Thrombosis and Haemostasis 2020; 1–4. https://doi.org/10.1111/jth.14768.

13. Hu H., Ma F., Wei X., Fang Y. Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin Hongde. European Heart Journal. 2020;1307800. https://doi.org/10.1093/eurheartj/ehaa190.

14. Chen C., Zhou Y., Wen Wang D. SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz. 2020;10–2. https://doi.org/10.1007/s00059-020-04909-z.

15. Zeng J.H., Liu Y., Yuan J., Wang F., Wu W., Li J., Wang L., Gao H., Wang Y., Dong C., Li Y., Xie X., Feng C., Liu L. First case of COVID-19 infection with fulminant myocarditis complication: case report and insights. Infection.2020;10:1-5. doi: 10.1007/s15010- 020-01424-5.

16. Luo W., Yu H., Gou J., Li X., Sun Y., Li J. Clinical pathology of critical patient with coronavirus pneumonia (COVID-19). Pre- Prints. 2020;1–14.

17. Xu X., Gao X. Immunological responses against SARS-coronavirus infection in humans. Cellular & Molecular Immunology. 2004;1(2):119–22.

18. Wang Y.D., Sin Wan-Yee Fion, Xu Guo-Bing, Yang Huang-Hua, Yong X. T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS. Journal of Virology. 2004;78(14):7861. https://doi.org/10.1128/JVI.78.11.5612–5618.

19. Alhogbani T. Acute myocarditis associated with novel Middle East respiratory syndrome coronavirus. Annals of Saudi Medicine. 2016;36(1):78– 80. https://doi.org/10.5144/0256-4947.2016.78.

20. Ruan Q., Yang K., Wang W., Jiang L., Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Medicine. 2020; 46(5):846-848. https://doi.org/10.1007/s00134-020-05991-x.

21. Mehta P., McAuley D. F., Brown M., Sanchez E., Tattersall R. S., Manson J. J. Correspondence COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;6736(20):19–20. https://doi.org/10.1016/S0140-6736(20)30628-0.

22. Chen G., Wu D., Guo W., Cao Y., Huang D., Wang H., Zhang X., Chen H., Yu H., Zhang X., Zhang M., Wu S., Song J., Chen T., Han M., Li S., Luo X., Zhao J., Ning Q. Clinical and immunologic features in severe and moderate forms of coronavirus disease 2019. Journal of Clinical Investigation.2020; 1;130 (5):2620- 2629. https://doi.org/10.1172/JCI137244.

23. Alvi R.M., Frigault M. J., Fradley M. G., Jain M. D., Mahmood S. S., Awadalla M., Lee D. H., Zlotoff D. A., Zhang L., Drobni Z. D., Malek Z. O., Bassily E., Isaac R., Ismail-Khan R., Mulligan C. P., Banerji D., Lazaryan A., Shah B. D., Rokicki A., Raje N., Chavez J. C., Abramson J., Locke F. L. Cardiovascular events among adults treated with chimeric antigen receptor T-cells (CAR-T). Journal of the American College of Cardiology. 2019;74(25):3099–108. https://doi.org/10.1016/j. jacc.2019.10.038.

24. Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., Wang B., Xiang H., Cheng Z., Xiong Y., Zhao Y., Li Y., Wang X., Peng Z. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA.2020;7;323(11):1061-1069. doi:10.1001/ jama.2020.1585.

25. Jing-Wei Li, Han Tian-Wen, Woodward M., Anderson C. S., Zhou H., Chen Yun-Dai, Neal B. The impact of 2019 novel coronavirus on heart injury: A Systematicreview and Meta-analysis. Progress in Cardiovascular Diseases. 2020; 16;S0033-0620 (20)30080-3. doi:10.1016 / j. pcad.2020.04.008.

26. Ying-Ying Zheng, Ma Yi-Tong, Jin-Ying Zhang, Xie X. COVID-19 and the cardiovascular system. Nature Reviews Cardiology. 2020;17(5):259- 260. doi: 10.1038/s41569-020-0360-5

27. Adriano N.C., Tagliari A. P., Forleo G. B., Fassini G. M., Tondo C. Cardiac and arrhythmic complications in patients with COVID‐19 Journal of Cardiovascular Electrophysiology. 2020;31 (5):1003- 1008. doi: 10.1111/jce.14479.

28. Yang X., Xu J., Shu H., Xia J., Liu H., Wu Y., Zhang L., Yu Z., Fang M., Yu T., Wang Y., Pan S., Zou X., Yuan S., Shang Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine. 2020;8(5):475-481. doi: 10.1016/S2213- 2600(20)30079-5.

29. He X.W., Lai J. S., Cheng J., Wang M. W., Liu Y. J., Xiao Z. C., Xu C., Li S. S., Zeng H. S. Impact of complicated myocardial injury on the clinical outcome of severe or critically ill COVID-19 patients. Zhonghua Xin Xue Guan Bing Za Zhi 2020;48,E011. doi: 10.3760/cma.j.cn112148-20200228-00137.

30. Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., Guan L., Wei Y., Li H., Wu X., Xu J., Tu S., Zhang Y., Chen H., Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet 2020;395(10229):1054-1062. https://doi.org/10.1016/S0140-6736(20)30566-3.

31. Fu L., Fei J., Xiang Hui-Xian, Xiang Y., Tan Zhu-Xia , Li Meng-Die, Liu Fang-Fang, Liu Hong- Yan, Zheng L., Li Y. Influence factors of death risk among COVID-19 patients in Wuhan, China: a hospital-based case-cohort study. MedRxiv.2020. doi: 10.1101/2020.03.13.20035329

32. Chen T., Wu D., Chen H., Yan W., Yang D., Chen G., Ma K., Xu D., Yu H., Wang H., Wang T., Guo W., Chen J., Ding C., Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091. doi: 10.1136/bmj.m1091.

33. Zhang F., Zhang F., Yang D., Li J., Gao P., Chen T., Cheng Z., Cheng K., Fang Q., Pan W., Fan H., Wu Y., Li L., Fang Y., Liu J., Tian G., He L. Myocardial injury is associated with in-hospital mortality of confirmed or suspected COVID-19 in Wuhan, China: a single center retrospective cohort study. MedRxiv; 2020. doi: 10.1101/2020.03.21.20040121

34. Liu Y., Li J., Liu D., Song H., Chen C. Clinical features and outcomes of 2019 novel coronavirusinfected patients with cardiac injury. MedRxiv; 2020. https://doi.org/10.1101/2020.03.11.20030957

35. Guo T., Fan Y., Chen M., Wu X., Zhang L., He T., Wang H., Wan J., Wang X., Lu Z. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID‐19). JAMA Cardiology. 2020.5(7):811-818. doi:10.1001/ jamacardio.2020.1017

36. Liu J., Zhang L., Zhu F., Xie L., Wang C., Wang J., Chen R. Clinical characteristics and treatment of patients infected with COVID-19 in Shishou, China. SSRN Pre-Print.. https://doi.org/10.2139/ssrn.3541147

37. Inciardi R.M., Lupi L., Zaccone G., Italia L., Raffo M., Tomasoni D., Cani D. S., Cerini M., Farina D., Gavazzi E., Maroldi R., Adamo M., Ammirati E., Sinagra G., Lombardi C. M., Metra M. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiology. 2020;5(7):1-6. https://doi.org/10.1001/jamacardio.2020.1096.

38. Stroup D.F., Berlin J. A., Morton S. C., Olkin I., Williamson G. D., Rennie D., Moher D., Becker B. J., Sipe T., Thacker A. S. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-2012. doi: 10.1001/jama.283.15.2008.

39. Rothman K.J., Greenland S, Lash T.L. Modern epidemiology. 2nd ed. USA: Lippincott Williams & Wilkins Publishers; 2008.

40. Cai Q., Huang D., Ou P. 2019-nCoV pneumonia in a normal work infectious diseases hospital besides Hubei Province, China. doi:10.2139/ ssrn.3542163

41. Lu H., Lu H., Ai J., Shen Y., Li Y., Li T., Zhou X., Zhang H. Zhang Q. Ling Y., Wang S., Qu H., Gao Y., Li Y., Zhu D., Zhu H., Tian R., Zeng M. A descriptive study of the impact of diseases control and prevention on the epidemics dynamics and clinical features of SARS-CoV-2 outbreak in Shanghai, lessons learned formetropolis epidemics prevention. MedRxiv Pre- Print; 2020. https://doi.org/10.1101/2020.02.19.20025031.

42. Shi S., Qin M., Shen B., Cai Y., Liu T., Yang F., Gong W., Liu X., Liang J., Zhao Q., Huang H., Yang B., Huang C. Association of cardiac injury with mortality in hospitalized patients with COVID‐19 in Wuhan, China. JAMA. 2020.25;5(7):802-810. doi: 10.1001/ jamacardio.2020.0950

43. Zheng Y-Y., Ma Yi-Tong, Zhang Jin-Ying, Xie X. COVID-19 and the cardiovascular system. Nature Reviews Cardiology. 2020. 17 (5): 1-2 doi: 10.1038/ s41569-020-0360-5.

44. Kulanthaivel S., Kaliberdenko V.B., Balasundaram K., Shterenshis M.V., Scarpellini E., Abenavoli L. Tocilizumab in SARS-COV-2 Patients with the Syndrome of Cytokine Storm; a Narrative review. Reviews on Recent Clinical Trials. 2020 Sep 17. Epub ahead of print. https://doi.org/10.2174/15748871156662009 17110954. PMID.

45. Wu Z., McGoogan J. M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;2019:3– 6.


Войти или Создать
* Забыли пароль?